Sharp Revenue Decline & Weakening FCFA steep revenue drop (~36%) and a near‑50% fall in free cash flow materially reduce internal funding for growth and returns. Even with healthy per‑BOE margins, weaker topline and FCF constrain discretionary spending, heighten reliance on liquidity, and increase vulnerability to further price or volume shocks.
Concentrated, Capital‑intensive H1 2026 With Execution RiskAn intense H1 program concentrating major campaigns (FPSO works, turnaround, multiple well interventions) raises simultaneous‑operations and logistics risk. Delays or cost overruns could push out production recovery, elevate cash burn during a capital‑heavy period, and impair the projected H2 cash rebound.
Who Dat Riser Leak And Near‑term Production RiskA riser leak impacting ~30% of Who Dat throughput requires phased rerouting and later repairs, reducing near‑term volumes. Reliance on non‑operated assets for meaningful production adds uncertainty, potentially depressing cash flows and making guidance sensitive to remediation timing and coordination with partners.